Integrated Filing — IndAS

General information about company
Scrip Code	526423
NSE Symbol	KRITI
MSEI Symbol	NOTLISTED
ISIN	INE479D01038
Name of company	KRITI INDUSTRIES (INDIA) LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	22-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	15-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	PLASTICS
Start date and time of board meeting	22-May-2025   10:15:00
End date and time of board meeting	22-May-2025   12:55:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2022-04-04
Indicate Company website link for updated RPT policy of the Company	https://kritiindustries.com/pdf/investor-desk/Policies/Policy-on-Related-Party-Transactions.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	Yes
No. of times funds raised during the quarter	1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
NIL

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	1375065000	7219067000
	Other income	10071000	36305000
	Total income	1385136000	7255372000
2	Expenses
(a)	Cost of materials consumed	1344261000	5789346000
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-264405000	-200510000
(d)	Employee benefit expense	94298000	381287000
(e)	Finance costs	61787000	239006000
(f)	Depreciation, depletion and amortisation expense	38968000	144550000
(f)	Other Expenses
1	other expenses	198577000	965480000
	Total other expenses	198577000	965480000
	Total expenses	1473486000	7319159000
3	Total profit before exceptional items and tax	-88350000	-63787000
4	Exceptional items	0	0
5	Total profit before tax	-88350000	-63787000
6	Tax expense
7	Current tax	-27000000	0
8	Deferred tax	-24880000	-18831000
9	Total tax expenses	-51880000	-18831000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	-36470000	-44956000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	-36470000	-44956000
17	Other comprehensive income net of taxes	1983000	-829000
18	Total Comprehensive Income for the period	-34487000	-45785000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	51104000	51104000
	Face value of equity share capital	1	1
27	Details of debt securities
22	Reserves excluding revaluation reserve		397500000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	-0.71	-0.88
	Diluted earnings (loss) per share from continuing operations	-0.66	-0.8
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	-0.71	-0.88
	Diluted earnings (loss) per share from continuing and discontinued operations	-0.66	-0.8
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		Notesttttttttttt n1 The above results have been reviewed by the Audit Committee in its meeting held on 21st May 2025 and taken on record by the Board of Directors in its meeting held on 22nd May 2025ttttttttttt n2 The consolidated financial statements include result of (a) the wholly owned subsidiary (WOS) Kriti Auto and Engineering Plastics Pvt Ltd and (b) Associate Company viz FP Elite Energy Private Limitedttttttttttt n3 The above financial results have been prepared in accordance with the Companies (Indian Accounting Standards) Rules 2015 (Ind AS) as amended prescribed under Section 133 of the Companies Act 2013 read with relevant rules issued thereunderttttttttttt n4 During the quarter and the year ended 31st March 2025 the Raw Material prices declined sharply impacting inventory valuation adversely ttttttttttt n5 The Group has only one Business Segment Plastics as per Ind AS 108 Operating Segmentsttttttttttt n6 The figures for quarter ended on 31st March 2025 and 31st March 2024 are balancing figures between the figure reviewed for the year ended on 31st March 2025 and 31st March 2024 and the figure reviewed for Nine months ended on 31st December 2024 and 31st December 2023 respectivelyttttttttttt n7 Pursuant to the special resolution passed at the Extraordinary General Meeting held on July 15 2024 and the relevant regulatory provisions the Company had allotted on July 27 2024 by way of preferential allotment 9461480 warrants at a price of Rs15850 each each warrant carrying an option to apply and be allotted upon being fully paid up within a period of 18 months from date of allotment one equity share of face value Re1 of the Company (including premium of Rs15750 per share) The subscription and allotment money - Rs374911 lakhs being 25% of the total warrant price was received during the second quarter and in accordance with earlier approval of shareholders and following early exercise of the option on payment of balance 75% payable in respect of 1500000 warrants [Rs1783125 lakhs] during the quarter ended March 2025 the Company issued and allotted 1500000 equity shares of face value of Re 1 of the Company (including premium of Rs157 50 each) to Kriti Nutrients Limited on 11th February 2025 Following this allotment the issued and paid-up Equity Share Capital of the Company comprises of 51103520 shares of Re1 eachttttttttttt n8 The statutory auditors have expressed an unmodified audit opinionttttttttttt ntttttttFor KRITI INDUSTRIES (INDIA) LIMITED tttt nttttttttttt nttttttttttt nttttttttttt nPlace Indoretttttttt(SHIV SINGH MEHTA)ttt nDate 22nd May 2025tttttt Chairman & Managing Directortttt n

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	1646402000
	Capital work-in-progress	205587000
	Investment property	119796000
	Goodwill	0
	Other intangible assets	238000
	Intangible assets under development
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	0
	Trade receivables, non-current
	Loans, non-current	0
	Other non-current financial assets	37339000
	Total non-current financial assets	37339000
	Deferred tax assets (net)	0
	Other non-current assets	0
	Total non-current assets	2009362000
2	Current assets
	Inventories	1589893000
	Current financial asset
	Current investments	0
	Trade receivables, current	486177000
	Cash and cash equivalents	733000
	Bank balance other than cash and cash equivalents	282885000
	Loans, current	0
	Other current financial assets
	Total current financial assets	769795000
	Current tax assets (net)	33049000
	Other current assets	391461000
	Total current assets	2784198000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	4793560000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	51104000
	Other equity	1950577000
	Total equity attributable to owners of parent	2001681000
	Non controlling interest
	Total equity	2001681000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	352334000
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	17326000
	Total non-current financial liabilities	369660000
	Provisions, non-current	17245000
	Deferred tax liabilities (net)	94660000
	Deferred government grants, Non-current
	Other non-current liabilities	46552000
	Total non-current liabilities	528117000
	Current liabilities
	Current financial liabilities
	Borrowings, current	721494000
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	16677000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	1277750000
	Total Trade payable	1294427000
	Other current financial liabilities	4782000
	Total current financial liabilities	2020703000
	Other current liabilities	219217000
	Provisions, current	23842000
	Current tax liabilities (Net)
	Deferred government grants, Current
	Total current liabilities	2263762000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	2791879000
	Total equity and liabilites	4793560000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
	Total Amount of items that will not be reclassified to profit and loss
2	Income tax relating to items that will not be reclassified to profit or loss	-1983000	829000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	1983000	-829000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			-63787000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			239006000
	Adjustments for decrease (increase) in inventories			-32489000
	Adjustments for decrease (increase) in trade receivables, current			181261000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-52309000
	Adjustments for decrease (increase) in other non-current assets			0
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			-5393000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-39377000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			13632000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			144550000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			7940000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			518000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			0
	Adjustments for dividend income			0
	Adjustments for interest income			27816000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			0
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			-826000
	Other adjustments for non-cash items			0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			428697000
	Net cash flows from (used in) operations			364910000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			29079000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			335831000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			0
	Purchase of property, plant and equipment			311404000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			137000
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			0
	Interest received			27816000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-82153000
	Net cash flows from (used in) investing activities	-365604000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			237750000
	Proceeds from issuing other equity instruments			315474000
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			271650000
	Payments of lease liabilities			0
	Dividends paid			9921000
	Interest paid			0
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-241246000
	Net cash flows from (used in) financing activities			30407000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			634000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			634000
	Cash and cash equivalents cash flow statement at beginning of period			100000
	Cash and cash equivalents cash flow statement at end of period			734000

Signatory Details
Name of signatory	Rajesh Sisodia
Designation of person	Chief Financial Officer
Place	Indore
Date	22-May-2025